Inactive Instrument

Transcripts Wilex AG Deutsche Boerse AG

Stocks

DE0006614720

Biotechnology & Medical Research

End-of-day quote Deutsche Boerse AG
- ^EUR	-

09-24	Heidelberg Pharma AG Presents New Clinical Data For Lead ATAC Candidate Pamlectabart Tismanitin At IMS Annual Meeting 2026	CI
09-07	Heidelberg Pharma AG Presents New Clinical Data On Lead ATAC Candidate Pamlectabart Tismanitin At International Myeloma Society Annual Meeting	CI

Transcripts

03-31	Heidelberg Pharma AG, 2025 Earnings Call, Mar 26, 2026
11-11	Heidelberg Pharma AG - Special Call
25-10-20	Heidelberg Pharma AG - Special Call
25-06-17	Heidelberg Pharma AG - Special Call
25-03-23	Heidelberg Pharma AG, 2024 Earnings Call, Mar 24, 2025
24-04-23	Heidelberg Pharma AG - Special Call
24-03-25	Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024
23-07-13	Heidelberg Pharma AG, H1 2023 Earnings Call, Jul 13, 2023
23-03-27	Heidelberg Pharma AG, 2022 Earnings Call, Mar 27, 2023
23-02-15	Heidelberg Pharma AG - Special Call
22-07-12	Heidelberg Pharma AG Provides Earnings Guidance for the Year 2022	CI
22-03-24	Heidelberg Pharma AG, 2021 Earnings Call, Mar 24, 2022
22-03-24	Heidelberg Pharma Ag Provides Earnings Guidance for the Year 2022	CI
22-02-28	Heidelberg Pharma AG - Special Call
21-07-19	Heidelberg Pharma AG Provides Financial Guidance for 2021	CI
21-07-08	Heidelberg Pharma AG, Q2 2021 Earnings Call, Jul 08, 2021
21-07-08	Heidelberg Pharma AG Provides Earnings Guidance for the Year 2021	CI
21-04-29	Heidelberg Pharma AG Reaffirms Earnings Guidance for 2021	CI
21-03-25	Heidelberg Pharma AG, 2020 Earnings Call, Mar 25, 2021
21-03-25	Heidelberg Pharma AG Provides Earnings Guidance for the Year 2021	CI
20-07-09	Heidelberg Pharma AG, Q2 2020 Earnings Call, Jul 09, 2020
20-07-09	Heidelberg Pharma Ag Re-Affirm Earnings Guidance for the Fiscal Year 2020	CI
20-06-25	Heidelberg Pharma AG Presents at European Biotech Investor Day 2020, Jun-25-2020 11:00 AM
20-04-23	Heidelberg Pharma AG Confirms Earnings Guidance for the Full-Year of 2020	CI
20-03-19	Heidelberg Pharma AG Provides Earnings Guidance for 2020	CI